Protease-activated Receptor 4 Limits Influenza A Virus Infection

被引：0
|
作者：
Tatsumi, Kohei
Schmedes, Clare M.
Butler, Emily
Mackman, Nigel
Antoniak, Silvio
机构：
来源：
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 2019年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A670
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Thrombin modifies growth, proliferation and apoptosis of human colon organoids: a protease-activated receptor 1-and protease-activated receptor 4-dependent mechanism
    Sebert, Morgane
    Denadai-Souza, Alexandre
    Quaranta, Muriel
    Racaud-Sultan, Claire
    Chabot, Sophie
    Lluel, Philippe
    Monjotin, Nicolas
    Alric, Laurent
    Portier, Guillaume
    Kirzin, Sylvain
    Bonnet, Delphine
    Ferrand, Audrey
    Vergnolle, Nathalie
    BRITISH JOURNAL OF PHARMACOLOGY, 2018, 175 (18) : 3656 - 3668
  • [32] Inhibiting protease-activated receptor 4 limits myocardial ischemia/reperfusion injury in rat hearts by unmasking adenosine signaling
    Strande, Jennifer L.
    Hsu, Anna
    Su, Jidong
    Fu, Xiangping
    Gross, Garrett J.
    Baker, John E.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2008, 324 (03): : 1045 - 1054
  • [33] Protective Role for Protease-Activated Receptor-2 against Influenza Virus Pathogenesis via an IFN-γ-Dependent Pathway
    Khoufache, Khaled
    LeBouder, Fanny
    Morello, Eric
    Laurent, Fabrice
    Riffault, Sabine
    Andrade-Gordon, Patricia
    Boullier, Severine
    Rousset, Perrine
    Vergnolle, Nathalie
    Riteau, Beatrice
    JOURNAL OF IMMUNOLOGY, 2009, 182 (12): : 7795 - 7802
  • [34] Protease-Activated Receptor 4 (PAR4): A Promising Target for Antiplatelet Therapy
    Rudinga, Gamariel Rwibasira
    Khan, Ghulam Jilany
    Kong, Yi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (02)
  • [35] Protease-activated receptor 3 is a second thrombin receptor in humans
    Hiroaki Ishihara
    Andrew J. Connolly
    Dewan Zeng
    Mark L. Kahn
    Yao Wu Zheng
    Courtney Timmons
    Tracy Tram
    Shaun R. Coughlin
    Nature, 1997, 386 : 502 - 506
  • [36] Protease-activated receptor 3 is a second thrombin receptor in humans
    Ishihara, H
    Connolly, AJ
    Zeng, DW
    Kahn, ML
    Zheng, YW
    Timmons, C
    Tram, T
    Coughlin, SR
    NATURE, 1997, 386 (6624) : 502 - 506
  • [37] Protease-activated receptor-4 induction of human corneal epithelial cytokines
    Strande, JL
    Kolot, S
    Prado, R
    Song, P
    Armstrong, CA
    Ansel, JC
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46
  • [38] Cathepsin G activates protease-activated receptor-4 in human platelets
    Sambrano, GR
    Huang, W
    Faruqi, T
    Mahrus, S
    Craik, C
    Coughlin, SR
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (10) : 6819 - 6823
  • [39] PAR4 (Protease-Activated Receptor 4) PARticularly Important 4 Antiplatelet Therapy
    Han, Xu
    Nieman, Marvin T.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2018, 38 (02) : 287 - 289
  • [40] Discovery of Potent Protease-Activated Receptor 4 Antagonists with in Vivo Antithrombotic Efficacy
    Miller, Michael M.
    Banville, Jacques
    Friends, Todd J.
    Gagnon, Mark
    Hangeland, Jon J.
    Lavallee, Jean-Francois
    Martel, Alain
    O'Grady, Harold
    Remillard, Roger
    Ruediger, Edward
    Tremblay, Francois
    Posy, Shana L.
    Allegretto, Nick J.
    Guarino, Victor R.
    Harden, David G.
    Harper, Timothy W.
    Hartl, Karen
    Josephs, Jonathan
    Malmstrom, Sarah
    Watson, Carol
    Yang, Yanou
    Mang, Ge
    Wong, Pancras
    Yang, Wongjing
    Bouvier, Michel
    Seiffert, Dietmar A.
    Wexler, Ruth R.
    Lawrence, R. Michael
    Priestley, E. Scott
    Marinier, Anne
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (16) : 7400 - 7416
12345